Smith Drug Company, Div. J M Smith Corporation, is the winner of the 2018 Distribution Management Award (DMA) for their implementation of a cloud-based predictive inventory management system (IMS). The DMA is awarded annually to HDA member companies that, through a collaborative partnership, enhance the efficiency, effectiveness and safety of the supply chain. Recipients must demonstrate measurable gains in productivity and reduction in costs in addition to implementing innovative technology, processes or programs across trading partners.Read more
Saul Factor, RPh named President, Smith Drug Company and Burlington Drug Company; Kevin Welch named President, Integra LTC Solution, LLC and QS/1
SPARTANBURG, S.C. – J M Smith Corporation has announced that its leading innovative technology solutions will now be under the leadership of Kevin Welch. Saul Factor, RPh, who was the President of QS/1, will lead the wholesale distribution business units Smith Drug Company and Burlington Drug Company.
“The decision to align our technology offerings under one leader was made to further enhance our customer focus. Kevin is a highly respected technology leader with a passion for moving pharmacy forward. Under his guidance, QS/1 and Integra customers can expect a commitment to technology excellence and responsiveness,” said Alan Turfe, CEO and Chairman, J M Smith Corporation. “During his time as President of QS/1, Saul led with transparency and a contagious drive to advance customer centricity and business excellence. I am looking forward to what Kevin and Saul will accomplish for our customers in their new roles.
Hurricane Harvey made its first landfall on the Texas coast at Rockport Friday August 25th as a Category 4 hurricane, and moved back out over the bay before making a second landfall as a Category 3 hurricane. Harvey's intense winds and prolonged heavy rainfall devastated the Texas coast and coastal areas in Louisiana, causing dangerous flooding and spawning tornadoes.
The Smith Drug Operations Team and the SmithPride Committee quickly organized an effort to provide much needed drinking water to the Gulf Coast area. Their goal was to provide 100 cases of water to the affected areas. Smith employees quickly gave from their hearts, donating both cash and supplies to the effort.
Matt Pike brings extensive pharmacy background to new position
SPARTANBURG, S.C. – Smith Drug Company (SDC) has announced that Matthew Pike has been named to the newly-created position of Associate Vice President of Strategy, Industry Relations. In this role, Pike will work with Smith Drug Company to develop and operationalize strategy designed to maximize efficiencies and market share. Pike will also leverage his background as a resource for industry relations.
“To have someone of Matt’s caliber on our team is a tremendous asset,” said Jeff Foreman, RPh, President, Smith Drug Company. “Matt brings a great deal of experience and knowledge of the industry. Our team has tremendous depth and expertise already, but Matt’s arrival strengthens it even more. Smith Drug Company is poised for success against the challenges that lie ahead, and our customers will benefit from this.”Read more
James C. Wilson Jr. to retire after 30 years with the company
SPARTANBURG, S.C. — The Board of Directors of J M Smith Corporation has confirmed Philip J. Ryan, III as Chief Financial Officer and appointed Kevin Welch to the role of Chief Technology Officer. Ryan will also assume the role of Treasurer following the retirement of James C. Wilson, Jr. on October 1, 2017. Wilson has been employed with the company since 1987, serving first as controller before being elected Treasurer and then being named CFO.
“These appointments are significant steps on the path towards leadership excellence and operational excellence. Both Phil and Kevin are highly respected experts in their fields,” said Alan Turfe, Chairman and CEO, J M Smith Corporation. “Their passion for our organization and their vision for moving it forward are impressive. I am looking forward to working with them in their expanded roles.